David H Fink

US Patent:

D539056, Mar 27, 2007

Filed:

May 10, 2006

Appl. No.:

29/246796

Inventors:

Keith Helmetag - Brooklyn NY, US
David Fink - Glendale CA, US
Mitch Scott - Sebring OH, US
Laurie Mobley - North Canton OH, US

Assignee:

National Inventor's Hall of Fame Foundation - Akron OH

International Classification:

0604

US Classification:

D 6470, D6446

US Patent:

7402672, Jul 22, 2008

Filed:

Dec 1, 2004

Appl. No.:

11/001533

Inventors:

Frank Halley - Chaville, FR
Gilles Dutruc-Rosset - Paris, FR
Yong Mi Choi-Sledeski - Belle Mead NJ, US
Gregory Bernard Poli - Bethlehem PA, US
David Marc Fink - Lebanon NJ, US
Gilles Doerflinger - Les Ulis, FR
Bao-Guo Huang - Bridgewater NJ, US
Ann Marie Gelormini - Hillsborough NJ, US
Juan Antonio Gamboa - New York NY, US
Andrew Giovanni - Flemington NJ, US
Joachim E. Roehr - Bernardsville NJ, US
Joseph T. Tsay - Bridgewater NJ, US
Fernando Camacho - Union NJ, US
William Joseph Hurst - Oxford NJ, US
Stephen Wayne Harnish - Wharton NJ, US
Yulin Chiang - Convent Station NJ, US

Assignee:

Aventis Pharmaceuticals Inc. - Bridgewater NJ

International Classification:

C07D 471/00

US Classification:

546113

Abstract:

The present invention discloses and claims compounds of formula (I).

US Patent:

7626027, Dec 1, 2009

Filed:

Apr 21, 2008

Appl. No.:

12/106681

Inventors:

Frank Halley - Chaville, FR
Gilles Dutruc-Rosset - Paris, FR
Yong Mi Choi-Sledeski - Belle Mead NJ, US
Gregory Bernard Poli - Bethlehem PA, US
David Marc Fink - Lebanon NJ, US
Gilles Doerflinger - Les Ulis, FR
Bao-Guo Huang - Bridgewater NJ, US
Ann Marie Gelormini - Hillborough NJ, US
Juan Anotonio Gamboa - New York NY, US
Andrew Giovanni - Flemington NJ, US
Joachim E. Roehr - Bernardsville NJ, US
Joseph T. Tsay - Bridgewater NJ, US
Fernando Camacho - Union NJ, US
William Joseph Hurst - Oxford NJ, US
Stephen Wayne Harnish - Wharton NJ, US
Yulin Chiang - Convent Station NJ, US

Assignee:

Aventis Pharmaceuticals Inc - Bridgewater NJ

International Classification:

C07D 471/02

US Classification:

546113

Abstract:

The present invention discloses and claims compounds of formula (I).

US Patent:

20130024216, Jan 24, 2013

Filed:

Jul 19, 2011

Appl. No.:

13/185659

Inventors:

David B. Fink - Bethesda MD, US

International Classification:

G06Q 10/00
G06Q 30/00
G07B 15/00
G06K 5/00

US Classification:

705 5, 235382, 705 1436, 705 13

Abstract:

A computer implemented method and apparatus of the present invention relates to the creation of a tangible result in the form of a priority access ticket with identifiable information for providing priority access to artistic performances, concerts, sporting or other cultural events at stadiums or other venues. The method may comprise receiving a request for priority access to a venue for a customer, collecting customer information required to provide priority access to the venue responsive to receipt of the request, verifying availability of priority access for the customer based on the collected customer information, receiving payment for the requested priority access, and providing a visually perceptible priority access ticket responsive to the verification of availability of priority access.

US Patent:

20130024218, Jan 24, 2013

Filed:

Jul 19, 2012

Appl. No.:

13/553319

Inventors:

David B. Fink - Bethesda MD, US

International Classification:

G06Q 10/02

US Classification:

705 5

Abstract:

A computer implemented method and apparatus of the present invention relates to the creation of a tangible result in the form of a priority access ticket with identifiable information for providing priority access to artistic performances, concerts, sporting or other cultural events at stadiums or other venues. The method may comprise receiving a request for priority access to a venue for a customer, collecting customer information required to provide priority access to the venue responsive to receipt of the request, verifying availability of priority access for the customer based on the collected customer information, receiving payment for the requested priority access, and providing a visually perceptible priority access ticket responsive to the verification of availability of priority access.

US Patent:

20130131804, May 23, 2013

Filed:

Jan 16, 2013

Appl. No.:

13/743004

Inventors:

OSIRIS THERAPEUTICS, INC. - Columbia MD, US
J. Mary Murphy - Baltimore MD, US
Robert Deans - Timonium MD, US
David J. Fink - Baltimore MD, US
Annemarie Moseley - Lutherville MD, US

Assignee:

OSIRIS THERAPEUTICS, INC. - Columbia MD

International Classification:

A61F 2/02

US Classification:

623 1412

Abstract:

A method of repairing and/or stabilizing a joint by administering mesenchymal stem cells to the joint. Such a method provides for the regeneration of cartilaginous tissue in the joint, including meniscal tissue.

US Patent:

52161641, Jun 1, 1993

Filed:

Feb 10, 1992

Appl. No.:

7/833484

Inventors:

Richard C. Effland - Bridgewater NJ
David Fink - Doylestown PA

Assignee:

Hoechst-Roussel Pharmaceuticals Incorporated - Somerville NJ

International Classification:

C07D21527

US Classification:

546157

Abstract:

Novel 5-amino-5,6,7,8-tetrahydroquinolines and related compounds, intermediates and processes for the preparation thereof, and methods for relieving memory dysfunction utilizing compounds or compositions thereof are disclosed.

US Patent:

53345991, Aug 2, 1994

Filed:

Mar 25, 1993

Appl. No.:

8/037134

Inventors:

Edward J. Glamkowski - Warren NJ
David M. Fink - Doylestown PA
Barbara E. Kurys - Elmwood Park NJ
Yulin Chiang - Convent Station NJ

Assignee:

Hoechst-Roussel Pharmaceuticals Inc. - Somerville NJ

International Classification:

C07D40104
C07D41304
C07D41704
A61K 3146

US Classification:

514304

Abstract:

This invention relates to compounds of the formula ##STR1## where X is --O--, --S-- or --NH--; Y is hydrogen, halogen and loweralkoxy; p is 1 or 2; n is 2, 3 or 4; R is hydrogen, loweralkyl, loweralkoxy, hydroxy, halogen, amino, loweralkylamino, nitro, loweralkylthio, trifiuoromethoxy, cyano, trifiuoromethyl, ##STR2## R. sub. 1 is hydrogen, loweralkyl, loweralkoxy, halogen, hydroxy, carboxyl, loweralkylamino, nitro, loweralkylthio, cyano, and trifiuoromethyl; m is 1 or 2; a pharmaceutically acceptable acid addition salt thereof and, where applicable the geometric and optical isomers and racemic mixtures thereof. The compounds and compositions of this invention are useful as antipsychotic as 5-HT. sub. 3 receptor antagonists and as inhibitors of the reuptake of serotonin.